首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 在线期刊 1998年 => 3期 =>对恶性肝门部胆管梗阻用自膨式金属..
对恶性肝门部胆管梗阻用自膨式金属内支架与内镜逆行胆管内引流疗效对比
The comparison of therapeutic effect using expandable metallic biliary endorosthesis and endoscopic retrobiliary drainage in patients of mallignant hilar biliary obstruction.
文章发布日期:2009年10月26日  来源:  作者:朱春兰; 朱雅琪; 何成华; 陶铸; 任旭; 刘家骥   点击次数:1712次  下载次数:614次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:本文回顾性地对比分析了采用自膨式金属内支架术(EMBE)和经内镜逆行胆管内引流术(ERBD)对20例恶性肝门部胆管梗阻(MHBO)病人的治疗情况。结果:有效减黄率:在ERBD和EMBE组分别为77.8%和88.9%;早期合并胆管炎发生率:ERBD和EMBE分别为55.6%和11.2%(P<0.001);支架梗阻和/或晚期胆管炎发生率两组分别为66.6%和37.4%(P<0.01);两组平均生存期分别为:159±76和254±84天(P<0.01)。结论:EMBE治疗MHBO较ERBD疗效好,早期胆管炎发生率低,支架不易阻塞,生存质量高。
【Abstract】:his paper retrospectively analysed and evaluated 20 patients with malignant hilar biliar obstruction (MHBO) in comparison with expandable metallic biliary endoprosthese (EMBE) and ERBD.Results:Complete drainage were achived the rate of relief jundics:ERBD and EMBE was 77.8% and 88.9% Separately.The rate of early complication of cholangitis:ERBD and EMBE was 55.6% and 11.2% separately (P<0.001).The rate of reobstruction:ERBD and EMBE was 66.6% and 37.4% separately (P<0.01).The mean survial days:ERBD and EMBE was 159±76 and  254±84days (P<0.01).Conclusion:The effects of EMBE is better than ERBD in treating MHBO,the rate of early complication of cholangitis the EMBE is better than ERBD in treating MHBO,is lower.Long standing patency of stent and reduced reobstruction,improved quality of life.
【关键字】:恶性肝门部胆管梗阻; ERBD; 自膨式金属内支架引流术
【Key words】:Malignant hilar biliary obstruction ERBD Expandable metallic biliary endorosthesis
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号